A carregar...
Population pharmacokinetic and exposure simulation analysis for cediranib (AZD2171) in pooled Phase I/II studies in patients with cancer
AIMS: A population pharmacokinetic (PK) model was developed for cediranib to simulate cediranib exposure for different doses, including comedication with strong uridine glucuronosyl transferase/P‐glycoprotein inducers such as rifampicin, in cancer patients. METHODS: Plasma concentrations and covaria...
Na minha lista:
| Publicado no: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5510068/ https://ncbi.nlm.nih.gov/pubmed/28213941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13266 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|